Stefan Gerner/LinkedIn
Nov 27, 2025, 03:30
Stefan Gerner on Safety of Tenecteplase Versus Alteplase for IVT
Stefan Gerner, Senior Physician at Erlangen University Hospital, shared on LinkedIn:
”IVT seems safe in acute ischemic stroke patients with present direct oral anticoagulation according to our real-world data.
TNK seems as safe and effective as rt-PA in this setting!”
Read the full article here.
Article: Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center
Authors: Lena Mers, Anna Bogdanova, Alexander Sekita, Ludwig Singer, Manuel Schmidt, Bernd Kallmuenzer, Stefan Schwab, Stefan T. Gerner
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia